P.S. Sears

机构：Merck & Co., Inc., Rahway, NJ, USA (United States)

发表论文 150 篇 · 总被引 7052 次 · h-index 36

代表论文

Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial (2023 · Journal of Infection · 被引 23)
Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States (2021 · Infectious Diseases and Therapy · 被引 22)
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections (2020 · The Pediatric Infectious Disease Journal · 被引 19)
Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of Age (2021 · The Pediatric Infectious Disease Journal · 被引 12)
thermostability of enzymes (2020 · Catalysis from A to Z · 被引 11)
A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (2025 · The Pediatric Infectious Disease Journal · 被引 5)